Duration of effusion after antibiotic treatment for acute otitis media: comparison of cefaclor and amoxicillin. 1982

E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper

A double-blind randomized clinical trial was conducted at two sites comparing cefaclor and amoxicillin for the treatment of acute otitis media with effusion in 214 children (293 ears). Each child underwent unilateral or bilateral tympanocentesis and then was randomly assigned to receive a 14-day course of either amoxicillin or cefaclor. The symptomatic clinical response was the same for the two antibiotics, with four children considered "treatment failures" in each antibiotic treatment group. By 14 days after entry into the study 59 of 106 children (55.7%) in the cefaclor group had ears that were effusion-free as compared to 40 of 97 children (41.2%) in the amoxicillin group (P = 0.05). When considering all children with effusion-free ears as well as those "improved" from their original status (those with bilateral middle ear effusions at entry but only unilateral after treatment), 68 of 106 children (64.2%) receiving cefaclor were effusion-free or "improved," compared to 43 of 97 children (44.3%) receiving amoxicillin (P = 0.01). However, by 42 days after entry the percentage of children whose ears were without effusion or "improved" was equal in both treatment groups (68.9% in the cefaclor group and 67.5% in the amoxicillin group). The reasons for the differences observed at 14 days after entry are not readily apparent.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D011677 Punctures Incision of tissues for injection of medication or for other diagnostic or therapeutic procedures. Punctures of the skin, for example may be used for diagnostic drainage; of blood vessels for diagnostic imaging procedures. Micropunctures,Micropuncture,Puncture
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
March 1984, American journal of diseases of children (1960),
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
August 1998, Journal of chemotherapy (Florence, Italy),
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
June 1983, Bulletin of the New York Academy of Medicine,
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
May 1985, Pediatrics,
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
January 1984, Pediatric infectious disease,
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
January 1985, Acta oto-laryngologica. Supplementum,
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
September 2014, The Journal of pediatrics,
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
January 1983, Pediatric infectious disease,
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
July 1998, The Pediatric infectious disease journal,
E M Mandel, and C D Bluestone, and H E Rockette, and M M Blatter, and K S Reisinger, and F P Wucher, and J Harper
March 1987, The Pediatric infectious disease journal,
Copied contents to your clipboard!